ADAM17 and related epithelial injury markers in bronchoalveolar lavage and blood distinguish COPD from controls
Our findings highlight an overabundance of ADAM17 and pADAM17 in COPD airways that is accentuated beyond smoking-induced changes. This broad catalytic-complex analysis has both combined individual biomarkers and discovered more novel disease-specific biomarkers that may all relate to the overarching functionality of ADAM17 in COPD, warranting further investigation into the role this enzyme plays in COPD pathogenesis.
Institutions
- Lund University (SE)
Publication Details
- Journal
- Respiratory Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1016/j.rmed.2025.108596
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Skånes universitetssjukhus
- Interreg